New antimicrobial agents in mastitis therapy

Mastitis in Dairy Production: Current Knowledge and Future Solutions

Volumn , Issue , 2005, Pages 53-57

  Soback, Stefan ^a   Saran, Arthur ^a  

^a KIMRON VETERINARY INSTITUTE   (Israel)

Author keywords

Antibiotics; MIC; Pharmacokinetics; Therapy

Indexed keywords

EID: 28044440940     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3920/978-90-8686-550-5     Document Type: Chapter

References (19)

1. Erskine R.J., Wilson R.C., Tyler J.W., McClure K.A., Nelson R.S., and H.J. Spears, 1995. Ceftiofur distribution in serum and milk from clinically normal cows and cows with experimental Escherichia coli-induced mastitis. Am J Vet Res. Apr; 56(4): p. 481-5.
2. Erskine R.J., Walker R.D., Bolin C.A., Bartlett P.C., and D.G. White. 2002. Trends in antibacterial susceptibility of mastitis pathogens during a seven-year period. J Dairy Sci. May; 85(5): p. 1111-8.
3. Erskine R.J., Bartlett P.C., VanLente J.L., and C.R. Phipps. 2002b. Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle. J Dairy Sci. Oct; 85(10): p. 2571-5.
4. Guerin-Faublee V., Carret G., and P. Houffschmitt. 2003. In vitro activity of 10 antimicrobial agents against bacteria isolated from cows with clinical mastitis. Vet Rec. Apr 12; 152(15): p. 466-71.
5. Jaglan P.S., Cox B.L., Arnold T.S., Kubicek M.F., Stuart D.J., and T.J. Gilbertson. 1990. Liquid chromatographic determination of desfuroylceftiofur metabolite of ceftiofur as residue in cattle plasma. J Assoc Off Anal Chem. Jan-Feb; 73(1): p. 26-30.
6. Limbert M., Isert D., Klesel N., Markus A., Seeger K., Seibert G., and E. Schrinner. 1991. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin. Antimicrob Agents Chemother. Jan; 35(1): p. 14-9.
7. Meunier D., Acar J.F., Martel J.L., Kroemer S., and M. Valle. 2004. Seven years survey of susceptibility to marbofloxacin of bovine pathogenic strains from eight European countries. Int J Antimicrob Agents. Sep; 24(3): p. 268-78.
8. Nickerson S.C., Owens W.E., Fox L.K., Scheifinger C.C., Shryock T.R., and T.E. Spike. 1999. Comparison of tilmicosin and cephapirin as therapeutics for Staphylococcus aureus mastitis at dry-off. J Dairy Sci. Apr; 82(4): p. 696-703.
9. Oliver S.P., Almeida R.A., Gillespie B.E., Ivey S.J., Moorehead H., Lunn P., Dowlen H.H., Johnson D.L., and K.C. Lamar. 2003. Efficacy of extended pirlimycin therapy for treatment of experimentally induced Streptococcus uberis intramammary infections in lactating dairy cattle. Vet Ther. Fall; 4(3): p. 299-308.
10. Oliver S.P., Gillespie B.E., Ivey S.J., Lewis M.J., Johnson D.L., Lamar K.C., Moorehead H., Dowlen H.H., Chester S.T., and J.W. Hallberg. 1990. Influence of prepartum pirlimycin hydrochloride or penicillin-novobiocin therapy on mastitis in heifers during early lactation. J Dairy Sci. Jun; 87(6): p. 1727-31.
11. Owens W.E., Xiang Z.Y., Ray C.H., and S.C. Nickerson. 1990. Determination of milk and mammary tissue concentrations of ceftiofur after intramammary and intramuscular therapy. J Dairy Sci. Dec; 73(12): p. 3449-56.
12. Owens W.E., Nickerson S.C., and C.H. Ray. 1999. Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation. J Dairy Sci. Mar; 82(3): p. 645-7.
13. Owens W.E., Nickerson S.C., Boddie R.L., Tomita G.M., and C.H. Ray. 2001. Prevalence of mastitis in dairy heifers and effectiveness of antibiotic therapy. J Dairy Sci. Apr; 84(4): p. 814-7.
14. Schneider M., Valle M., Woehrle F., and B. Boisrame. 2004. Pharmacokinetics of marbofloxacin in lactating cows after repeated intramuscular administrations and pharmacodynamics against mastitis isolated strains. J Dairy Sci. Jan; 87(1): p. 202-11.
15. Shpigel N.Y., Levin D., Winkler M., Saran A., Ziv G., and A. Bottner. 1997. Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli. J Dairy Sci. Feb; 80(2): p. 318-23.
16. Taponen S., Jantunen A., Pyorala E., and S. Pyorala. 2003. Efficacy of targeted 5-day combined parenteral and intramammary treatment of clinical mastitis caused by penicillin-susceptible or penicillin-resistant Staphylococcus aureus. Acta Vet Scand.; 44(1-2): p. 53-62.
17. Thornsberry C., Marler J.K., Watts J.L., and R.J. Yancey Jr., 1993. Activity of pirlimycin against pathogens from cows with mastitis and recommendations for disk diffusion tests. Antimicrob Agents Chemother. May; 37(5): p. 1122-6.
18. Whittem T. 1999. Pharmacokinetics and milk discard times of pirlimycin after intramammary infusion: a population approach. J Vet Pharmacol Ther. Feb; 22(1): p. 41-51
19. Ziv G., Shem-Tov M., Glickman A., Winkler M., and A. Saran. 1995. Tilmicosin antibacterial activity and pharmacokinetics in cows. J Vet Pharmacol Ther. Oct; 18(5): p. 340-5.